Blog
NVIDIA's Strong Q4 Still Understates Its Potential
Share prices may have tumbled shortly after the earnings report numbers were posted, but there's no denying NVIDIA (NASDAQ: NVDA) had a stellar fourth quarter. Sales were up 61% year over year
2 Unstoppable Cannabis Stocks That Are Better Buys Than Sundial Growers
Cannabis company Sundial Growers has been on fire lately. Its stock price has skyrocketed 122% in the past three months, even after a big recent pullback. If this meteoric rise was due to the pure
2 Smart Stocks to Play the Coronavirus Economic Recovery
The stock market has been a flurry of contradictions lately, marking daily record highs followed by days of sharp decline. During times of volatility, it's important to remember that the stock
A High-Potential Basket of Small Bank Stocks
The mega banks can make excellent investments, but if you're looking for tons of growth potential, you'll probably have to think smaller. Fortunately, there are some excellent small-cap bank stocks
Stock Values Are Soaring Again. Here's How to Invest in Light of That.
Last week, stocks closed out on a low note. This week, things have turned around. On the one hand, that's a good thing -- it means any on-paper or on-screen losses you may have seen in your
The 10 Best Marijuana Stocks in February
Following a more than one-year downtrend, there's no longer any doubt about it: Marijuana stocks are back in a big way.
Cannabis projects as one of the fastest-growing industries this decade, with a
Here's What Fannie Mae Sees as a Big Risk to the Market
In January, Fannie Mae (OTC: FNMA) released its latest economic and housing outlook, where it provided its forecast for the housing market and broader economy in the coming years. In that report
Why It's Time to Go All-In on These 3 Revolutionary Stocks
For investors looking for highly innovative firms with asymmetrical risk-reward profiles -- the hunt is over. Virgin Galatic Holdings (NYSE: SPCE), CRISPR Therapeutics (NASDAQ: CRSP), and Churchill
Nano-X Imaging: Buy the Dip?
Just a couple of weeks ago, shares of Nano-X Imaging (NASDAQ: NNOX) traded hands for $87 per share. Now you can buy that same stock for $46 a share. That's a lot cheaper. Does that make it a buy?
Is Cash a Problem for Canopy Growth?
After alcoholic beverage giant Constellation Brands invested $4 billion in Canopy Growth (NASDAQ: CGC) a few years ago, the cannabis producer was in a great position to grow its business. But just
3 Signs You're Ready for Your First Social Security Check
You can start your Social Security benefits as early as age 62. But being eligible for benefits and actually being ready to claim them are not the same thing. In fact, if you make a hasty decision
Novavax's COVID Vaccine Trial: Are There Any Yellow Flags So Far?
Novavax (NASDAQ: NVAX) has completed enrollment in its late-stage study of COVID-19 vaccine NVX-CoV2373 that's being conducted in the U.S. and Mexico. The biotech recently released some details
Here's What the FDA Liked About Johnson & Johnson's COVID Vaccine
Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine is now the third to win emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). What did the FDA like about J&J's
This Canadian Pot Stock Is Copying Canopy Growth's U.S. Moves
When Canopy Growth (NASDAQ: CGC) announced plans to acquire Acreage Holdings in 2019, it was an innovative and unique way for the company to position itself for growth in the U.S. market ahead of
Should You Buy Tilray Stock Before the Aphria Merger?
The clock is ticking on the completion of the biggest marijuana merger ever. Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) expect to close their planned merger in the second quarter of this year.
5 Popular Stocks to Avoid Like the Plague in March
For three weeks shy of one year, investors have enjoyed one of the greatest bounce-back rallies in history. Since hitting its bear market lows on March 23, 2020, the benchmark S&P 500 and
AstraZeneca Just Sold Its Moderna Stock: Should You?
How long should you hold on to a winning stock? That question is an important one -- and not just for small investors. Even big companies that invest in smaller companies must decide when to cash in
3 Dividend Stocks Ideal for Retirees
Whether you're nearing retirement or already there, you want low-volatility investments that generate income during your golden years. Investing in dividend stocks is a smart way to accomplish both
Moderna's CEO Calls These 3 Elements "Critical" for Vaccine Success
Moderna (NASDAQ: MRNA) has been among the first to address the biggest challenge facing coronavirus vaccines right now: new variants of concern. These strains put the effectiveness of current
3 Value Stocks That'll Make You Richer in March (and Beyond)
For more than a decade, growth stocks have left value stocks eating their dust. Historically low lending rates and a record-long bull-market run have wet the appetites of investors looking for
3 Reasons to Save in an IRA Instead of Your Employer's 401(k)
Employer sponsored 401(k) plans have their benefits. For one thing, contributing to them is as easy as can be. All you do is tell your payroll department how much money you want to put in, and those
3 Great Ways to Invest Your $1,400 Stimulus Check
The House of Representatives recently passed the latest COVID-19 relief bill, which means we're one step closer to receiving a third round of stimulus checks.
The new relief bill includes $1,400
Neuronetics, Inc. (STIM) Q4 2020 Earnings Call Transcript
Image source: The Motley Fool.
Neuronetics, Inc. (NASDAQ: STIM)Q4 2020 Earnings CallMar 02, 2021, 8:30 a.m. ET
Operator
Source Fool.com
Ambarella (AMBA) Q4 2021 Earnings Call Transcript
Image source: The Motley Fool.
Ambarella (NASDAQ: AMBA)Q4 2021 Earnings CallMar 02, 2021, 4:30 p.m. ET
Operator
Source Fool.com
Why PubMatic Stock Jumped 63% in February
Shares of PubMatic (NASDAQ: PUBM) soared last month after the supply side ad tech firm posted strong fourth-quarter earnings results in its first report as a publicly traded company.
According to